Cite
HARVARD Citation
Nozawa, K. et al. (2022). Clinical Utility of Precision Medicine in Early Breast Cancer: What Is the Optimal Framework to Develop Precision Medicine?. Journal of clinical oncology. 40 (17), pp. 1962-1963. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nozawa, K. et al. (2022). Clinical Utility of Precision Medicine in Early Breast Cancer: What Is the Optimal Framework to Develop Precision Medicine?. Journal of clinical oncology. 40 (17), pp. 1962-1963. [Online].